Literature DB >> 22019515

Micromanaging the classification of colon cancer: the role of the microRNAome.

Eduardo Vilar1, Josep Tabernero, Stephen B Gruber.   

Abstract

Recent advances in our understanding of the microRNAome (miRNAome) have provided further insights into the molecular pathogenesis of colorectal cancer and shown a potential role for miRNAs in distinguishing molecular subtypes. The mucosa-adenoma-carcinoma model can now integrate miRNAs into the known genetic alterations that drive the progression of colorectal neoplasia. ©2011 AACR.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22019515      PMCID： PMC3422018          DOI： 10.1158/1078-0432.CCR-11-2440

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  14 in total

Review 1.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

2.  Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer.

Authors:  Angela N Bartley; Hui Yao; Bedia A Barkoh; Cristina Ivan; Bal M Mishra; Asif Rashid; George A Calin; Rajyalakshmi Luthra; Stanley R Hamilton
Journal:  Clin Cancer Res       Date:  2011-09-23       Impact factor: 12.531

Review 3.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

Review 4.  Microsatellite instability in colorectal cancer-the stable evidence.

Authors:  Eduardo Vilar; Stephen B Gruber
Journal:  Nat Rev Clin Oncol       Date:  2010-02-09       Impact factor: 66.675

5.  Colorectal cancers with microsatellite instability display unique miRNA profiles.

Authors:  Francesc Balaguer; Leticia Moreira; Juan Jose Lozano; Alexander Link; Georgina Ramirez; Yan Shen; Miriam Cuatrecasas; Mildred Arnold; Stephen J Meltzer; Sapna Syngal; Elena Stoffel; Rodrigo Jover; Xavier Llor; Antoni Castells; C Richard Boland; Meritxell Gironella; Ajay Goel
Journal:  Clin Cancer Res       Date:  2011-08-15       Impact factor: 12.531

6.  Inheritance of a cancer-associated MLH1 germ-line epimutation.

Authors:  Megan P Hitchins; Justin J L Wong; Graeme Suthers; Catherine M Suter; David I K Martin; Nicholas J Hawkins; Robyn L Ward
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

7.  Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

Authors:  Arnaud D Roth; Sabine Tejpar; Mauro Delorenzi; Pu Yan; Roberto Fiocca; Dirk Klingbiel; Daniel Dietrich; Bart Biesmans; György Bodoky; Carlo Barone; Enrique Aranda; Bernard Nordlinger; Laura Cisar; Roberto Labianca; David Cunningham; Eric Van Cutsem; Fred Bosman
Journal:  J Clin Oncol       Date:  2009-12-14       Impact factor: 44.544

8.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

Authors:  Marjolijn J L Ligtenberg; Roland P Kuiper; Tsun Leung Chan; Monique Goossens; Konnie M Hebeda; Marsha Voorendt; Tracy Y H Lee; Danielle Bodmer; Eveline Hoenselaar; Sandra J B Hendriks-Cornelissen; Wai Yin Tsui; Chi Kwan Kong; Han G Brunner; Ad Geurts van Kessel; Siu Tsan Yuen; J Han J M van Krieken; Suet Yi Leung; Nicoline Hoogerbrugge
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

Review 9.  PARsing the phrase "all in for Axin"- Wnt pathway targets in cancer.

Authors:  Eric R Fearon
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

Review 10.  MicroRNAs in colorectal cancer: translation of molecular biology into clinical application.

Authors:  Ondrej Slaby; Marek Svoboda; Jaroslav Michalek; Rostislav Vyzula
Journal:  Mol Cancer       Date:  2009-11-14       Impact factor: 27.401
View more
  6 in total

1.  MiR-486-5p Downregulation Marks an Early Event in Colorectal Carcinogenesis.

Authors:  Katherine A Kelley; Nicole Wieghard; Yuki Chin; Amiee Potter; Motomi Mori; Melissa H Wong; Koei Chin; V Liana Tsikitis
Journal:  Dis Colon Rectum       Date:  2018-11       Impact factor: 4.585

2.  MicroRNA polymorphisms and risk of colorectal cancer.

Authors:  Stephanie L Schmit; Jeremy Gollub; Michael H Shapero; Shu-Chen Huang; Hedy S Rennert; Andrea Finn; Gad Rennert; Stephen B Gruber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-23       Impact factor: 4.254

3.  Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis.

Authors:  Frank W Chen; Vandana Sundaram; Thomas A Chew; Uri Ladabaum
Journal:  Clin Gastroenterol Hepatol       Date:  2016-11-14       Impact factor: 11.382

4.  MicroRNAs as Novel Biomarkers in Colorectal Cancer.

Authors:  Sonja Hrašovec; Damjan Glavač
Journal:  Front Genet       Date:  2012-10-19       Impact factor: 4.599

5.  Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type.

Authors:  Zheng Wang; Zhaoshi Bao; Wei Yan; Gan You; Yinyan Wang; Xuejun Li; Wei Zhang
Journal:  J Exp Clin Cancer Res       Date:  2013-08-29

6.  MiR-1260b inhibitor enhances the chemosensitivity of colorectal cancer cells to fluorouracil by targeting PDCD4/IGF1.

Authors:  Jun Zhao; Jingjie Cao; Lurong Zhou; Yunyi Du; Xiaoling Zhang; Bo Yang; Yangjun Gao; Yu Wang; Ning Ma; Wei Yang
Journal:  Oncol Lett       Date:  2018-08-14       Impact factor: 2.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.